• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Generic versus disease-specific measures of health-related quality of life in systemic lupus erythematosus.

作者信息

Strand Vibeke, Chu Alvina D

出版信息

J Rheumatol. 2011 Sep;38(9):1821-3. doi: 10.3899/jrheum.110766.

DOI:10.3899/jrheum.110766
PMID:21885504
Abstract
摘要

相似文献

1
Generic versus disease-specific measures of health-related quality of life in systemic lupus erythematosus.系统性红斑狼疮中健康相关生活质量的通用测量方法与疾病特异性测量方法
J Rheumatol. 2011 Sep;38(9):1821-3. doi: 10.3899/jrheum.110766.
2
Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL).成人系统性红斑狼疮患者健康相关生活质量的测量：狼疮生活质量量表（LupusQoL）、系统性红斑狼疮特异性生活质量问卷（SLEQOL）和系统性红斑狼疮生活质量问卷（L-QoL）。
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S413-9. doi: 10.1002/acr.20636.
3
EuroQol is a useful instrument for assessing the health-related quality of life of the patients with systemic lupus erythematosus.欧洲五维度健康量表是评估系统性红斑狼疮患者健康相关生活质量的一种有用工具。
Lupus. 2005;14(4):334-5. doi: 10.1191/0961203305lu2084xx.
4
Quality-of-life measurements versus disease activity in systemic lupus erythematosus.系统性红斑狼疮的生活质量测量与疾病活动度比较。
Curr Rheumatol Rep. 2010 Aug;12(4):250-8. doi: 10.1007/s11926-010-0114-1.
5
Health-related quality of life assessed by LupusQoL questionnaire and SF-36 in Turkish patients with systemic lupus erythematosus.通过狼疮生活质量问卷（LupusQoL）和SF-36对土耳其系统性红斑狼疮患者的健康相关生活质量进行评估。
Clin Rheumatol. 2016 Mar;35(3):617-22. doi: 10.1007/s10067-015-2930-1. Epub 2015 Apr 7.
6
Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?是否有一种针对系统性红斑狼疮的生活质量衡量标准优于 SF-36？
J Rheumatol. 2011 Sep;38(9):1898-905. doi: 10.3899/jrheum.110007. Epub 2011 Jul 1.
7
Quality of life in children with systemic lupus erythematosus: a review.系统性红斑狼疮患儿的生活质量：综述
Lupus. 2007;16(8):663-9. doi: 10.1177/0961203307077539.
8
The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.SLEQOL 中文版是评估汉族系统性红斑狼疮患者健康相关生活质量的可靠工具。
Clin Rheumatol. 2018 Jan;37(1):151-160. doi: 10.1007/s10067-017-3910-4. Epub 2017 Nov 22.
9
Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist.系统性红斑狼疮患者的健康相关生活质量：狼疮特异性症状清单的编制与验证
Qual Life Res. 2003 Sep;12(6):635-44. doi: 10.1023/a:1025176407776.
10
Reduced Aerobic Capacity and Quality of Life in Physically Inactive Patients With Systemic Lupus Erythematosus With Mild or Inactive Disease.身体活动不足的轻度或非活动性系统性红斑狼疮患者的有氧能力和生活质量降低
Arthritis Care Res (Hoboken). 2016 Dec;68(12):1780-1786. doi: 10.1002/acr.22905. Epub 2016 Oct 28.

引用本文的文献

1
"…Not Having the Real Support That We Need": Patients' Experiences with Ambiguity of Systemic Lupus Erythematosus and Erosion of Social Support.“……没有我们所需的真正支持”：系统性红斑狼疮患者对病情不明及社会支持受损的体验
ACR Open Rheumatol. 2019 May;1(3):135-144. doi: 10.1002/acr2.1020. Epub 2019 Apr 22.
2
Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies.贝利尤单抗对系统性红斑狼疮患者报告结局的影响：临床研究综述
Patient Relat Outcome Meas. 2019 Jan 9;10:1-7. doi: 10.2147/PROM.S134326. eCollection 2019.
3
Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment.
贝利尤单抗对红斑狼疮患者健康相关生活质量和疲劳的长期影响：六年治疗。
Arthritis Care Res (Hoboken). 2019 Jun;71(6):829-838. doi: 10.1002/acr.23788. Epub 2019 Apr 29.
4
Patient Uncertainty Questionnaire-Rheumatology (PUQ-R): development and validation of a new patient-reported outcome instrument for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in a mixed methods study.患者不确定性问卷-风湿病学（PUQ-R）：一项混合方法研究中针对系统性红斑狼疮（SLE）和类风湿关节炎（RA）的新型患者报告结局工具的开发与验证
Health Qual Life Outcomes. 2016 Mar 1;14:33. doi: 10.1186/s12955-016-0432-8.
5
Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research.测量成年系统性红斑狼疮患者的疾病活动度：临床研究中管理负担和对患者关切问题的响应所面临的挑战。
Arthritis Res Ther. 2015 Jul 20;17(1):183. doi: 10.1186/s13075-015-0702-6.
6
Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.系统性红斑狼疮临床试验的患者报告结局指标：内容效度、表面效度和心理测量性能综述
Health Qual Life Outcomes. 2014 Jul 22;12:116. doi: 10.1186/s12955-014-0116-1.
7
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006.依帕珠单抗治疗中重度活动期狼疮性肾炎的随机对照 ALLEVIATE 试验及其扩展研究 SL0006 中的健康相关生活质量结局和皮质类固醇使用
Rheumatology (Oxford). 2014 Mar;53(3):502-11. doi: 10.1093/rheumatology/ket378. Epub 2013 Nov 22.
8
The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey.系统性红斑狼疮对患者生产力和职业发展的巨大负担：一项欧洲患者驱动的在线调查。
Rheumatology (Oxford). 2013 Dec;52(12):2292-301. doi: 10.1093/rheumatology/ket300. Epub 2013 Sep 18.
9
Predictors of self-reported health-related quality of life in systemic lupus erythematosus.系统性红斑狼疮患者报告的健康相关生活质量的预测因素。
Rheumatology (Oxford). 2013 Sep;52(9):1651-7. doi: 10.1093/rheumatology/ket171. Epub 2013 May 16.
10
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials.在随机对照 BLISS 试验中，B 淋巴细胞刺激物特异性抑制剂贝利尤单抗可改善自身抗体阳性系统性红斑狼疮患者的健康相关生活质量。
Ann Rheum Dis. 2014 May;73(5):838-44. doi: 10.1136/annrheumdis-2012-202865. Epub 2013 Mar 22.